ClinicalTrials.govpublic full text
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
myelodysplastic syndromes, anemia, mds, bone marrow disease, hs-20106, ker-050, fusion protein, tgf-β, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 857855
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.